GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genfit SA (FRA:XUPB) » Definitions » Short Interest

Genfit (FRA:XUPB) Short Interest


View and export this data going back to 2020. Start your Free Trial

What is Genfit Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Genfit's Short Interest

For the Biotechnology subindustry, Genfit's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genfit's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genfit's Short Interest distribution charts can be found below:

* The bar in red indicates where Genfit's Short Interest falls into.


;
;

Genfit Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genfit SA (FRA:XUPB) » Definitions » Short Interest
Comparable Companies
XPAR:NANO XPAR:IPH XPAR:ALCLS XPAR:IVA XPAR:OSE XPAR:ALSEN XPAR:DBV XPAR:TNG XPAR:MAAT XPAR:ADOC VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
GNFT:USA 0QT6:UK GNFT:France XUP:Germany
Address
Parc Eurasante, 885, Avenue Eugene Avinee, Loos, FRA, 59120
Website
https://www.genfit.com
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Genfit Headlines

No Headlines